StockpollyBeta
Get App
Popularity #1,377
AQST · NASDAQ · Drug Manufacturers - Specialty & Generic

Aquestive Therapeutics (AQST)

Develops PharmFilm oral medicines and manufactures licensed films for global partners.

$4.97
vs last close+0.19 (+3.91%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue13131220141291013131414
Cost of revenue554545455634
Gross profit898169755871110
111217161721241720361518
Research & development336455545344
71011111216191315331114
Selling & marketing000000000002
General & administrative0000000000012
Operating income−2−4−90−8−14−19−11−11−29−4−8
0−4−4−3−3−3−4−2−4−3−4−15
Interest income200111000001
Interest expense134444444444
Other non-operating income−210−1−1−1−1−20−1011
Income before tax−2−8−13−3−12−17−23−14−15−32−8−23
Income tax expense000000000000
Net income from continuing operations−2−8−13−3−12−17−23−14−15−32−8−23
Net income−2−8−13−3−12−17−23−14−15−32−8−23
EPS, basic−$0.03−$0.12−$0.17−$0.03−$0.13−$0.19−$0.24−$0.14−$0.14−$0.26−$0.07−$0.18
EPS, diluted−$0.03−$0.12−$0.17−$0.03−$0.13−$0.19−$0.24−$0.14−$0.14−$0.26−$0.07−$0.18
Weighted average shares, basic6569749191919599111122123125
Weighted average shares, diluted6569749191919599111122123125
EBITDA−1−4−82−7−13−19−9−11−27−4−19
Depreciation & amortization000000000000
EBIT−1−5−91−7−13−19−9−11−28−4−19